32 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NXTM NxStage Medical, Inc. $28.33 $1.86B N/A
Article Searches
NxStage Medical Inc (NXTM) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/02/nxstage-medical-inc-nxtm-q1-2019-earnings-call-tra.aspx?source=iedfolrf0000001 May 02, 2019 - NXTM earnings call for the period ending March 31, 2019.
4 Healthcare Stocks Likely to Beat Estimates in Q4 http://www.zacks.com/stock/news/351056/4-healthcare-stocks-likely-to-beat-estimates-in-q4?cid=CS-ZC-FT-351056 Jan 31, 2019 - An aging population, prevalence of chronic health conditions and greater utilization of healthcare services should drive the industry's growth, partly offset by an increase in expenses.
Will NxStage Medical (NXTM) Report Negative Earnings Next Week? What You Should Know http://www.zacks.com/stock/news/335922/will-nxstage-medical-nxtm-report-negative-earnings-next-week-what-you-should-know?cid=CS-ZC-FT-335922 Nov 07, 2018 - NxStage (NXTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NxStage Medical (NXTM) Reports Q2 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/323892/nxstage-medical-nxtm-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-323892 Sep 19, 2018 - NxStage (NXTM) delivered earnings and revenue surprises of 20.00% and 1.54%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
NxStage Just Got This Vital Lifeline https://www.fool.com/investing/2018/08/10/nxstage-just-got-this-vital-lifeline.aspx?source=iedfolrf0000001 Aug 10, 2018 - Here's the good news the dialysis specialist needed.
NxStage Keeps Losing Money as Key Deadline Grows Nearer https://www.fool.com/investing/2018/05/14/nxstage-keeps-losing-money-as-key-deadline-grows-n.aspx?source=iedfolrf0000001 May 14, 2018 - Find out why concerns about the dialysis specialist's merger are getting worse.
NxStage Medical (NXTM) Q1 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/05/10/nxstage-medical-nxtm-q1-2018-earnings-conference-c.aspx?source=iedfolrf0000001 May 10, 2018 - NXTM earnings call for the period ending March 31, 2018.
Wider Losses Worry NxStage Medical Shareholders https://www.fool.com/investing/2018/02/26/wider-losses-worry-nxstage-medical-shareholders.aspx?source=iedfolrf0000001 Feb 26, 2018 - An increasing discount to the buyout price for the dialysis specialist's stock is raising concerns.
NxStage Nx2me Connected Health Improves Home Hemodialysis http://www.zacks.com/stock/news/285528/nxstage-nx2me-connected-health-improves-home-hemodialysis?cid=CS-ZC-FT-285528 Dec 11, 2017 - NxStage Medical (NXTM) consistently looks to expand dialysis platform.
Here's Why You Should Offload Fresenius Medical Stock Now http://www.zacks.com/stock/news/283734/heres-why-you-should-offload-fresenius-medical-stock-now?cid=CS-ZC-FT-283734 Nov 22, 2017 - Fresenius (FMS) grapples with multiple issues. An unfavorable estimate revision trend adds to the woes.

Pages: 1234

Page 1>